Literature DB >> 20622071

Depression and cardiovascular disease: selected findings, controversies, and clinical implications from 2009.

Karina W Davidson1, Maya Rom Korin.   

Abstract

We systematically searched published empirical research on depression and cardiovascular disease (CVD) and found 494 unique articles published in 2009. Several particularly notable and provocative findings and controversies emerged from this survey of the 2009 literature. First, multiple large observational studies found that antidepressant use was associated with increased risk of incident stroke, CVD, or sudden cardiac death. Second, four randomized controlled trials on depression interventions in CVD patients reported important efficacy results that should guide future trials. Finally, the vigorous debate on whether patients with CVD should be routinely screened (and subsequently treated) for depression continued in 2009 even as some observed that routine screening for CVD in depressed patients is more evidence-based and appropriate. This article reviews these selected provocative findings and controversies from our search and explores their clinical implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622071      PMCID: PMC2917844          DOI: 10.3949/ccjm.77.s3.04

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  34 in total

1.  Learning from history: a commentary on the American Heart Association Science Advisory on depression screening.

Authors:  Brett D Thombs; Lisa R Jewett; Ruby Knafo; James C Coyne; Roy C Ziegelstein
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

2.  Psychotropic medication: curing illness or creating problems?

Authors:  Kate Jolly; Michael J S Langman
Journal:  Heart       Date:  2009-09-23       Impact factor: 5.994

3.  Depression and cardiac risk: present status and future directions.

Authors:  Nancy Frasure-Smith; François Lespérance
Journal:  Heart       Date:  2009-10-26       Impact factor: 5.994

4.  Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  D S Krantz; K S Whittaker; J L Francis; T Rutledge; B D Johnson; G Barrow; C McClure; D S Sheps; K York; C Cornell; V Bittner; V Vaccarino; W Eteiba; S Parashar; D A Vido; C N Bairey Merz
Journal:  Heart       Date:  2009-08-06       Impact factor: 5.994

5.  Sertraline treatment of major depression in patients with acute MI or unstable angina.

Authors:  Alexander H Glassman; Christopher M O'Connor; Robert M Califf; Karl Swedberg; Peter Schwartz; J Thomas Bigger; K Ranga Rama Krishnan; Louis T van Zyl; J Robert Swenson; Mitchell S Finkel; Charles Landau; Peter A Shapiro; Carl J Pepine; Jack Mardekian; Wilma M Harrison; David Barton; Michael Mclvor
Journal:  JAMA       Date:  2002-08-14       Impact factor: 56.272

6.  Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.

Authors:  Jordan W Smoller; Matthew Allison; Barbara B Cochrane; J David Curb; Roy H Perlis; Jennifer G Robinson; Milagros C Rosal; Nanette K Wenger; Sylvia Wassertheil-Smoller
Journal:  Arch Intern Med       Date:  2009-12-14

7.  Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Authors:  Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; William S Harris
Journal:  JAMA       Date:  2009-10-21       Impact factor: 56.272

8.  Screening for depression and suicidality in patients with cardiovascular illnesses.

Authors:  Eyal Shemesh; Rachel A Annunziato; David Rubinstein; Sarah Sultan; Jotinder Malhotra; Mugdha Santra; Beth D Weatherley; John R Feaganes; Gad Cotter; Rachel Yehuda
Journal:  Am J Cardiol       Date:  2009-11-01       Impact factor: 2.778

9.  Sudden death in patients receiving drugs tending to prolong the QT interval.

Authors:  Kate Jolly; Michael D Gammage; Kar Keung Cheng; Peter Bradburn; Miriam V Banting; Michael J S Langman
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

10.  Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial.

Authors:  Bruce L Rollman; Bea Herbeck Belnap; Michelle S LeMenager; Sati Mazumdar; Patricia R Houck; Peter J Counihan; Wishwa N Kapoor; Herbert C Schulberg; Charles F Reynolds
Journal:  JAMA       Date:  2009-11-16       Impact factor: 56.272

View more
  9 in total

1.  Association of Midlife Cardiorespiratory Fitness With Incident Depression and Cardiovascular Death After Depression in Later Life.

Authors:  Benjamin L Willis; David Leonard; Carolyn E Barlow; Scott B Martin; Laura F DeFina; Madhukar H Trivedi
Journal:  JAMA Psychiatry       Date:  2018-09-01       Impact factor: 21.596

2.  Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study.

Authors:  Emmanuelle Corruble; Caroline Barry; Isabelle Varescon; Antoine Durrbach; Didier Samuel; Philippe Lang; Denis Castaing; Bernard Charpentier; Bruno Falissard
Journal:  BMC Psychiatry       Date:  2011-11-21       Impact factor: 3.630

Review 3.  Depression in Cardiovascular Patients in Middle Eastern Populations: A Literature Review.

Authors:  Tam Truong Donnelly; Jassim Mohd Al Suwaidi; Awad Al-Qahtani; Nidal Asaad; Najlaa Abdul Qader; Rajvir Singh; Tak Shing Fung; Irem Mueed; Shima Sharara; Noha El Banna; Sarah Omar
Journal:  J Immigr Minor Health       Date:  2015-08

4.  Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Thomas Rutledge; Tanya S Kenkre; Vera Bittner; David S Krantz; Diane V Thompson; Sarah E Linke; Jo-Ann Eastwood; Wafia Eteiba; Carol E Cornell; Viola Vaccarino; Carl J Pepine; B Delia Johnson; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2013-02-12       Impact factor: 4.164

5.  The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients.

Authors:  Murat Kesim; Ahmet Tiryaki; Mine Kadioglu; Efnan Muci; Nuri Ihsan Kalyoncu; Ersin Yaris
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

6.  Clinical and scientific progress related to the interface between cardiology and psychology: lessons learned from 35 years of experience at the Thoraxcenter of the Erasmus Medical Center in Rotterdam.

Authors:  R A M Erdman; S S Pedersen
Journal:  Neth Heart J       Date:  2011-11       Impact factor: 2.380

7.  Loneliness, Depression, and Inflammation: Evidence from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Briana Mezuk; Moon Choi; Amy S DeSantis; Stephen R Rapp; Ana V Diez Roux; Teresa Seeman
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

8.  Associations between increased circulating endothelial progenitor cell levels and anxiety/depressive severity, cognitive deficit and function disability among patients with major depressive disorder.

Authors:  Ying-Jay Liou; Mu-Hong Chen; Ju-Wei Hsu; Kai-Lin Huang; Po-Hsun Huang; Ya-Mei Bai
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

9.  Anxiety and hemodynamic reactivity during cardiac stress testing: The role of gender and age in myocardial ischemia.

Authors:  Maria T Bekendam; Paula M C Mommersteeg; Willem J Kop; Jos W Widdershoven; Ilse A C Vermeltfoort
Journal:  J Nucl Cardiol       Date:  2020-02-28       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.